Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells--significant roles of CXCL10.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Research

• Publication date

  2009-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-08-2915PMID 19190335PMCID PMC5450639
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recruitment and activation of natural killer cells in vitro by a human dendritic cell vaccine.

  2008influential reference
• Inhibition of STAT3 Promotes the Efficacy of Adoptive Transfer Therapy Using Type-1 CTLs by Modulation of the Immunological Microenvironment in a Murine Intracranial Glioma1

  2008cited by this paper
• Molecular strategies for the treatment of malignant glioma—genes, viruses, and vaccines

  2008cited by this paper
• Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation.

  2008influential reference
• Helper function of memory CD8+ T cells: heterologous CD8+ T cells support the induction of therapeutic cancer immunity.

  2007cited by this paper
• Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

  2007cited by this paper
• Preferential expression of very late antigen-4 on type 1 CTL cells plays a critical role in trafficking into central nervous system tumors.

  2007cited by this paper
• Polarized Type-1 Dendritic Cells (DC1) Producing High Levels of IL-12 Family Members Rescue Patient TH1-type Antimelanoma CD4+ T cell Responses In Vitro

  2007cited by this paper
• Recent advances in immunotherapy for human glioma

  2006cited by this paper
• Adoptive transfer of type 1 CTL mediates effective anti-central nervous system tumor response: critical roles of IFN-inducible protein-10.

  2006cited by this paper
• Identification of interleukin-13 receptor alpha2 peptide analogues capable of inducing improved antiglioma CTL responses.

  2006cited by this paper
• Identification of a glioma antigen, GARC‐1, using cytotoxic T lymphocytes induced by HSV cancer vaccine

  2006cited by this paper
• Delivery of Dendritic Cells Engineered to Secrete IFN-α into Central Nervous System Tumors Enhances the Efficacy of Peripheral Tumor Cell Vaccines: Dependence on Apoptotic Pathways1

  2005cited by this paper
• EphA2 as a glioma-associated antigen: a novel target for glioma vaccines.

  2005cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• IL-4-Transfected Tumor Cell Vaccines Activate Tumor-Infiltrating Dendritic Cells and Promote Type-1 Immunity1

  2005cited by this paper
• Regulation of immune responses by L-arginine metabolism

  2005cited by this paper
• Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.

  2005cited by this paper
• Polarization of naive T cells into Th1 or Th2 by distinct cytokine‐driven murine dendritic cell populations: implications for immunotherapy

  2005cited by this paper
• alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity.

  2004cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004influential reference
• Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors

  2004cited by this paper
• Delivery of Interferon-α Transfected Dendritic Cells into Central Nervous System Tumors Enhances the Antitumor Efficacy of Peripheral Peptide-Based Vaccines

  2004cited by this paper
• Sequential delivery of interferon-α gene and DCs to intracranial gliomas promotes an effective antitumor response

  2004cited by this paper
• Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model.

  2003cited by this paper
• Differential effects of IL‐12 on the generation of alloreactive CTL mediated by murine and human dendritic cells: a critical role for nitric oxide

  2003cited by this paper
• Identification of a Novel HLA-A*0201-restricted, Cytotoxic T Lymphocyte Epitope in a Human Glioma-associated Antigen, Interleukin 13 Receptor α2 Chain

  2002cited by this paper
• IFN-γ-Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and Trafficking1

  2002cited by this paper
• Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain.

  2002cited by this paper
• Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas.

  2002cited by this paper
• The Brain Parenchyma Is Permissive for Full Antitumor CTL Effector Function, Even in the Absence of CD4 T Cells1

  2000cited by this paper
• Development of Th1-Inducing Capacity in Myeloid Dendritic Cells Requires Environmental Instruction1

  2000cited by this paper
• Immunobiology of dendritic cells.

  2000influential reference
• gp100/pmel 17 Is a Murine Tumor Rejection Antigen: Induction of “Self”-reactive, Tumoricidal T Cells Using High-affinity, Altered Peptide Ligand

  1998cited by this paper
• Bone marrow‐derived dendritic cells pulsed with a tumor‐specific peptide elicit effective anti‐tumor immunity against intracranial neoplasms

  1998cited by this paper
• Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes

  1996cited by this paper
• Constitutive Expression of Interferon Y-inducible Protein 10 in Lymphoid Organs and Inducible Expression in T Cells and Thymocytes

  1994cited by this paper
• Constitutive expression of interferon gamma-inducible protein 10 in lymphoid organs and inducible expression in T cells and thymocytes

  1994cited by this paper
• Association of class I major histocompatibility heavy and light chains induced by viral peptides

  1989cited by this paper
• Journal of Translational Medicine Toll like Receptor-3 Ligand Poly-iclc Promotes the Efficacy of Peripheral Vaccinations with Tumor Antigen-derived Peptide Epitopes in Murine Cns Tumor Models

  year unknowncited by this paper

• Shear Stress and Microbubble‐Mediated Modulation of Endothelial Cell Immunobiology

  2025cites this paper
• Systematic Analysis of an Immune-Related Gene Signature for Predicting Prognosis and Immune Characteristics in Primary Lower Grade Glioma

  2025cites this paper
• CpG ODN Activates TLR9 and Upregulates TLR3 via the p38 MAPK-ATF3 Signaling Axis to Synergistically Enhance Dendritic Cell Vaccine Efficacy

  2025cites this paper
• Mendelian randomization and mediation analysis reveal the role of immune cells in the pathways between inflammatory factors and glioblastoma

  2025cites this paper
• Adipocyte-derived CXCL10 in obesity promotes the migration and invasion of ovarian cancer cells

  2024cites this paper
• Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches

  2024cites this paper
• Identification of Hub Genes and Biological Mechanisms Associated with Non-Alcoholic Fatty Liver Disease and Triple-Negative Breast Cancer

  2023cites this paper
• Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update

  2023cites this paper
• Unbiased chemokine receptor screening reveals similar efficacy of lymph node- and tumor-targeted T cell immunotherapy

  2023cites this paper
• DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open

  2023cites this paper
• The duality of CXCR3 in glioblastoma: unveiling autocrine and paracrine mechanisms for novel therapeutic approaches

  2023influential citation
• Targeting the pericyte antigen DLK1 with an alpha type-1 polarized dendritic cell vaccine results in tumor vascular modulation and protection against colon cancer progression

  2023cites this paper
• Delivery of CXCL9/10/11 plasmid DNAs promotes the tumor-infiltration of T cells and synergizes with PD1 antibody for treating lung cancer

  2022cites this paper
• Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment

  2022cites this paper
• CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma

  2022cites this paper
• Tumor Immunogenic Cell Death as a Mediator of Intratumor CD8 T-Cell Recruitment

  2022cites this paper
• Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma

  2022cites this paper
• CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors

  2021cites this paper
• Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis

  2021cites this paper
• Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End

  2021cites this paper
• Advances in Chemokine Signaling Pathways as Therapeutic Targets in Glioblastoma

  2021cites this paper
• Type 1 conventional dendritic cells and interferons are required for spontaneous CD4+ and CD8+ T‐cell protective responses to breast cancer

  2021cites this paper
• Understanding stem cells and its pivotal role in regenerative medicine.

  2021cites this paper
• Opening of the Blood–Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models

  2021cites this paper
• MicroRNA-200c restoration reveals a cytokine profile to enhance M1 macrophage polarization in breast cancer

  2021cites this paper
• Prognostic and predictive values of CXCL10 in colorectal cancer

  2020cites this paper
• CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond

  2020cites this paper
• Significance of Intracellular Adhesion Molecule-1 Polymorphism and IP-10 among Breast Cancer Patients.

  2020cites this paper
• Adipose-derived stem cell therapy inhibits the deterioration of cerebral infarction by altering macrophage kinetics.

  2019cites this paper
• Immune Checkpoint Inhibitors

  2019cites this paper
• Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma

  2018cites this paper
• The therapeutic potential of human adipose-derived mesenchymal stem cells producing CXCL10 in a mouse melanoma lung metastasis model.

  2018cites this paper
• Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas

  2017cites this paper
• Efficacy of Combination Therapy with MET and VEGF Inhibitors for MET-overexpressing Glioblastoma.

  2017cites this paper
• Combination of DESI2 and IP10 gene therapy significantly improves therapeutic efficacy against murine carcinoma

  2017cites this paper
• Tumor Immuno-Environment in Cancer Progression and Therapy.

  2017cites this paper
• Influx and Efflux of Immune Cells in the Central Nervous System

  2017cites this paper
• MHC class II peptides induce CD8+CD44+Ly49+ regulatory T cells in C57BL/6 mice.

  2017cites this paper
• Approaches to Improve Efficiency of Dendritic Cell-based Therapy of High Grade Gliomas.

  2016cites this paper
• Dendritic Cell Therapy-A promising approach in Cancer treatment

  2016cites this paper
• CXCL10 Expression Status is Prognostic in Patients with Advanced Thoracic Esophageal Squamous Cell Carcinoma

  2016cites this paper
• CCR2-Dependent Dendritic Cell Accumulation in the Central Nervous System during Early Effector Experimental Autoimmune Encephalomyelitis Is Essential for Effector T Cell Restimulation In Situ and Disease Progression

  2015cites this paper
• Biomedical insights into cell adhesion and migration—from a viewpoint of central nervous system tumor immunology

  2015cites this paper
• Increasing glioma-associated monocytes leads to increased intratumoral and systemic myeloid-derived suppressor cells in a murine model.

  2015cites this paper
• Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome

  2015cites this paper
• Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme

  2015cites this paper
• Principles of immunology and its nuances in the central nervous system.

  2015cites this paper
• Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity.

  2015cites this paper
• Overview of current immunotherapeutic strategies for glioma.

  2015cites this paper
• A Systemic Review of Clinical Trials on Dendritic-Cells Based VaccineAgainst Malignant Glioma

  2015cites this paper
• Histamine deficiency promotes accumulation of immunosuppressive immature myeloid cells and growth of murine gliomas

  2015cites this paper
• The Lymphoid Chemokine CCL21 Enhances the Cytotoxic T Lymphocyte‐Inducing Functions of Dendritic Cells

  2014cites this paper
• University of Dundee Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue Rentoft,

  2014cites this paper
• Human IP10-scFv and DC-induced CTL synergistically inhibit the growth of glioma in a xenograft model

  2014cites this paper
• STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment

  2014influential citation
• Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells

  2014cites this paper
• Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC

  2014cites this paper
• Disease Progression for Effector T Cell Restimulation In Situ and Autoimmune Encephalomyelitis Is Essential during Early Effector Experimental Accumulation in the Central Nervous System CCR2-Dependent Dendritic Cell

  2014cites this paper
• The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer.

  2014cites this paper
• Clinical use of dendritic cells for cancer therapy.

  2014cites this paper
• Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue

  2014cites this paper
• Synergy between CD8 T Cells and Th1 or Th2 Polarised CD4 T Cells for Adoptive Immunotherapy of Brain Tumours

  2013cites this paper
• Anti-tumor and pro-tumor interactions of human NK cells in cancer

  2013cites this paper
• GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α.

  2013cites this paper
• A novel recombinant protein of IP10-EGFRvIIIscFv and CD8+ cytotoxic T lymphocytes synergistically inhibits the growth of implanted glioma in mice

  2013cites this paper
• Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-GM-CSF Promotes the Immunosuppressive Activity of

  2013cites this paper
• Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts

  2013cites this paper
• Dendritic Cells Pulsed with Viral Oncolysate

  2013cites this paper
• The Versatile World of Inflammatory Chemokines in Cancer

  2013cites this paper
• In Vivo Intracellular Oxygen Dynamics in Murine Brain Glioma and Immunotherapeutic Response of Cytotoxic T Cells Observed by Fluorine-19 Magnetic Resonance Imaging

  2013cites this paper
• IMMUNOTHERAPEUTIC ACTION OF T-BET GENE MODIFIED DENDRITIC CELLS

  2013influential citation
• Dendritic Cell-Based Immunotherapy for Glioma: Multiple Regimens and Implications in Clinical Trials

  2013cites this paper
• Extranodal induction of therapeutic immunity in the tumor microenvironment after intratumoral delivery of Tbet gene-modified dendritic cells

  2013cites this paper
• Premetastatic soil and prevention of breast cancer brain metastasis.

  2013cites this paper
• α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial

  2012cites this paper
• Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.

  2012cites this paper
• Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation.

  2012cites this paper
• Combination of Caspy2 and IP-10 Gene Therapy Significantly Improves Therapeutic Efficacy Against Murine Malignant Neoplasm Growth and Metastasis

  2012cites this paper
• Lymphocyte-polarized DC1s

  2012cites this paper
• Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets.

  2012cites this paper
• Enhancement of protective immunity against intracellular bacteria using type-1 polarized dendritic cell (DC) vaccine.

  2012cites this paper
• Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model

  2012cites this paper
• Inhibitory roles of signal transducer and activator of transcription 3 in antitumor immunity during carcinogen-induced lung tumorigenesis.

  2012cites this paper
• The interaction of NK cells and dendritic cells in the tumor environment: how to enforce NK cell & DC action under immunosuppressive conditions?

  2012cites this paper
• Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay

  2012cites this paper
• Lymphocyte-polarized dendritic cells are highly effective in inducing tumor-specific CTLs.

  2012cites this paper
• Zoledronate Sensitizes Neuroblastoma-derived Tumor-initiating Cells to Cytolysis Mediated by Human &ggr;&dgr; T Cells

  2012cites this paper
• 19 Immunotherapeutic Strategies for Brain Tumors

  2012cites this paper
• Novel mechanisms of cytokine signaling on T-cell and MDSC function in glioma development

  2012cites this paper
• DENDRITIC CELLS REGULATE THE INDUCTION OF EFFECTOR AND MEMORY CD8+ T CELLS

  2012influential citation
• Lung Tumorigenesis Transcription 3 in Antitumor Immunity during Carcinogen-Induced Inhibitory Roles of Signal Transducer and Activator of

  2012cites this paper
• Application of Carbon Nanotubes to Brain Tumor Therapy

  2012cites this paper
• Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.

  2011cites this paper
• The emerging role of CXCL10 in cancer (Review).

  2011cites this paper
• Improved composition for inhibition of tumour cell proliferation

  2011cites this paper
• Dendritic cells and immunity against cancer

  2011cites this paper
• Immunotherapeutic Strategies for Brain Tumors

  2011cites this paper
• Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model

  2011cites this paper
• COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells.

  2011influential citation
• Therapeutics , Targets , and Chemical Biology COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells

  2011cites this paper